![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » AIDA PHARMACEUTICALS, INC. ACQUIRES 77.5% OF CHINESE GENE DRUG PIONEER SHANGHAI QIAER BIO-TECHNOLOGY
AIDA PHARMACEUTICALS, INC. ACQUIRES 77.5% OF CHINESE GENE DRUG PIONEER SHANGHAI QIAER BIO-TECHNOLOGY
Aida Pharmaceuticals, Inc., one of mainland China's leading pharmaceutical companies, announced that the Company has completed its acquisition of the majority control of Shanghai Qiaer Bio-Technology Co., Ltd. BioSpace (http://www.biospace.com/news_story.aspx?StoryId=27273)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct